Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB3 in Healthy Male Subjects
Clinical trial NCT02075073 · COMPLETED
Trial details
- NCT number
- NCT02075073
- Sponsor
- Samsung Bioepis Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-04-01
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.